Lantern Pharma Raises $4.4 Million in Registered Direct Offering, Plans to Spin Out AI Platform
Lantern Pharma announced a $4.4 million registered direct offering and plans to create an independent entity for its AI platform, withZeta.ai, signaling a strategic shift to monetize its technology.